Reviva Pharmaceuticals
RVPH
RVPH
16 hedge funds and large institutions have $4.68M invested in Reviva Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.12% less ownership
Funds ownership: 18.69% → 12.57% (-6.1%)
38% less capital invested
Capital invested by funds: $7.54M → $4.68M (-$2.87M)
Holders
16
Holding in Top 10
–
Calls
$230K
Puts
$25K
Top Buyers
| 1 | +$34K | |
| 2 | +$31K | |
| 3 | +$7.21K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.73K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$71.1K | |
| 3 | -$7.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 5 |
BlackRock
New York
|
-$4.89K |